← Back to Search

Intervention Arm for Chronic Obstructive Pulmonary Disease (TLAL Trial)

N/A
Waitlist Available
Led By Mohit Bhutani, MD, FRCPC
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

TLAL Trial Summary

This study will enroll patients who present to Emergency Departments (EDs) and have an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD) or asthma at discharged in one Edmonton ED. Patients will all be provided with evidence-based discharge (prednisone and an antibiotic for COPD and prednisone and inhaled corticosteroids for asthma) and will be randomized to receive enhanced education to the primary care provider or standard care. The investigators' goal is to determine if an opinion leaders' advice will improve chronic care in these patients.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease

TLAL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Adjusted management
Follow-up with primary care provider
Length of ED Stay
+3 more

TLAL Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Opinion leader educational letter
Group II: Control/Standard CareActive Control1 Intervention
Regular care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Opinion leader educational letter
2011
N/A
~130

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
886 Previous Clinical Trials
384,780 Total Patients Enrolled
GlaxoSmithKlineIndustry Sponsor
4,749 Previous Clinical Trials
8,067,300 Total Patients Enrolled
Mohit Bhutani, MD, FRCPCPrincipal InvestigatorUniversity of Alberta

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Lung Attack Alert Study
2011. "The Lung Attack Alert Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01107613.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top